Page 24 - NON-INVASIVE TESTS FOR EVALUATION OF LIVER DISEASE SEVERITY AND PROGNOSIS
P. 24
[118] Wong VW, Wong GL, Chim AM, Tse AM, Tsang SW, Hui AY, et al. Validation JOURNAL OF HEPATOLOGY
of the NAFLD fibrosis score in a Chinese population with low prevalence of
advanced fibrosis. Am J Gastroenterol 2008;103:1682–1688. [140] Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, et al.
Assessment of liver fibrosis by transient elastography in persons with
[119] Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect
Gastroenterol Hepatol 2013;10:666–675. Dis 2009;48:963–972.
[120] Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum [141] Pineda JA, Recio E, Camacho A, Macias J, Almodovar C, Gonzalez-Serrano M,
marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006;44: et al. Liver stiffness as a predictor of esophageal varices requiring therapy
462–474. in HIV/hepatitis C virus-coinfected patients with cirrhosis. J Acquir
Immune Defic Syndr 2009;51:445–449.
[121] Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, et al.
Comparison of test performance profile for blood tests of liver fibrosis in [142] Sanchez-Conde M, Montes-Ramirez ML, Miralles P, Alvarez JM, Bellon JM,
chronic hepatitis C. J Hepatol 2007;46:395–402. Ramirez M, et al. Comparison of transient elastography and liver biopsy for
the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients
[122] Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, et al. and correlation with noninvasive serum markers. J Viral Hepat
Prospective comparison of six non-invasive scores for the diagnosis of liver 2010;17:280–286.
fibrosis in chronic hepatitis C. J Hepatol 2007;46:775–782.
[143] Castera L, Winnock M, Pambrun E, Paradis V, Perez P, Loko MA, et al.
[123] Cales P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, et al. Comparison of transient elastography (FibroScan), FibroTest, APRI and two
Evaluating the accuracy and increasing the reliable diagnosis rate of blood algorithms combining these non-invasive tests for liver fibrosis staging in
tests for liver fibrosis in chronic hepatitis C. Liver Int 2008;28:1352–1362. HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collab-
oration. HIV Med 2014;15:30–39.
[124] Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, et al.
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomark- [144] Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L,
ers in chronic viral hepatitis: a multicenter prospective study (the et al. Accuracy of liver stiffness measurement for the diagnosis of
FIBROSTIC study). J Hepatol 2010;53:1013–1021. cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:
1511–1517.
[125] Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, et al.
Comparison of nine blood tests and transient elastography for liver fibrosis [145] Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction
in chronic hepatitis C: The ANRS HCEP-23 study. J Hepatol 2012;56:55–62. of hepatitis C-related fibrosis: a systematic review of diagnostic test
accuracy. Am J Gastroenterol 2007;102:2589–2600.
[126] Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al.
Prospective comparison of transient elastography, Fibrotest, APRI, and liver [146] Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-
biopsy for the assessment of fibrosis in chronic hepatitis C. based transient elastography for the detection of hepatic Fibrosis:
Gastroenterology 2005;128:343–350. systematic review and meta-analysis. Clin Gastroenterol Hepatol
2007;5:1214–1220.
[127] Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al.
Noninvasive assessment of liver fibrosis by measurement of stiffness in [147] Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al.
patients with chronic hepatitis C. Hepatology 2005;41:48–54. Performance of transient elastography for the staging of liver fibrosis: a
meta-analysis. Gastroenterology 2008;134:960–974.
[128] Lupsor M, Badea R, Stefanescu H, Grigorescu M, Sparchez Z, Serban A, et al.
Analysis of histopathological changes that influence liver stiffness in [148] Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al. A
chronic hepatitis C. Results from a cohort of 324 patients. J Gastrointestin meta-analysis of transient elastography for the detection of hepatic
Liver Dis 2008;17:155–163. fibrosis. J Clin Gastroenterol 2010;44:214–219.
[129] Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, et al. [149] Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR,
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis Burroughs AK. Elastography for the diagnosis of severity of fibrosis in
in patients with hepatitis B or C: a United States multicenter study. Clin chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol
Gastroenterol Hepatol 2015;13:e773. 2011;54:650–659.
[130] Oliveri F, Coco B, Ciccorossi P, Colombatto P, Romagnoli V, Cherubini B, [150] Chon YE, Choi EH, Song KJ, Park JY, Kim do Y, Han KH, et al. Performance of
et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker transient elastography for the staging of liver fibrosis in patients with
of liver disease influenced by the pattern of transaminases. World J chronic hepatitis B: a meta-analysis. PLoS One 2012;7:e44930.
Gastroenterol 2008;14:6154–6162.
[151] Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Ledinghen V, Douvin C,
[131] Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. et al. Assessment of liver fibrosis using transient elastography in patients
Non-invasive assessment of liver fibrosis by stiffness measurement in with alcoholic liver disease. J Hepatol 2008;49:1062–1068.
patients with chronic hepatitis B. Liver Int 2009;29:242–247.
[152] Fraquelli M, Rigamonti C, Casazza G, Donato MF, Ronchi G, Conte D, et al.
[132] Chan HL, Wong GL, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Alanine Etiology-related determinants of liver stiffness values in chronic viral
aminotransferase-based algorithms of liver stiffness measurement by hepatitis B or C. J Hepatol 2011;54:621–628.
transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
J Viral Hepat 2009;16:36–44. [153] Maimone S, Calvaruso V, Pleguezuelo M, Squadrito G, Amaddeo G, Jacobs
M, et al. An evaluation of transient elastography in the discrimination of
[133] Kim do Y, Kim SU, Ahn SH, Park JY, Lee JM, Park YN, et al. Usefulness of HBeAg-negative disease from inactive hepatitis B carriers. J Viral Hepat
FibroScan for detection of early compensated liver cirrhosis in chronic 2009;16:769–774.
hepatitis B. Dig Dis Sci 2009;54:1758–1763.
[154] Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, et al. An
[134] Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, et al. accurate definition of the status of inactive hepatitis B virus carrier by a
FibroScan and ultrasonography in the prediction of hepatic fibrosis in combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS One
patients with chronic viral hepatitis. J Gastroenterol 2009; 44:439–446. 2008;3:e2573.
[135] Sporea I, Sirli R, Deleanu A, Tudora A, Popescu A, Curescu M, et al. Liver [155] Castera L, Bernard PH, Le Bail B, Foucher J, Trimoulet P, Merrouche W, et al.
stiffness measurements in patients with HBV vs. HCV chronic hepatitis: a Transient elastography and biomarkers for liver fibrosis assessment and
comparative study. World J Gastroenterol 2010;16:4832–4837. follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther
2011;33:455–465.
[136] Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP,
et al. Direct comparison of diagnostic performance of transient elas- [156] Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, et al.
tography in patients with chronic hepatitis B and chronic hepatitis C. Liver Noninvasive assessment of liver fibrosis by measurement of stiffness in
Int 2012;32:612–621. patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis
2008;40:371–378.
[137] Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, et al.
Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. [157] Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, et al.
J Gastroenterol Hepatol 2013;28:1738–1745. Accuracy and reproducibility of transient elastography for the diagnosis of
fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008;48:
[138] de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. 442–448.
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/
hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr [158] Lupsor M, Badea R, Stefanescu H, Grigorescu M, Serban A, Radu C, et al.
2006;41:175–179. Performance of unidimensional transient elastography in staging non-
alcoholic steatohepatitis. J Gastrointestin Liver Dis 2010;19:53–60.
[139] Vergara S, Macias J, Rivero A, Gutierrez-Valencia A, Gonzalez-Serrano M,
Merino D, et al. The use of transient elastometry for assessing liver fibrosis [159] Petta S, Di Marco V, Camma C, Butera G, Cabibi D, Craxi A. Reliability of liver
in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis stiffness measurement in non-alcoholic fatty liver disease: the effects of
2007;45:969–974. body mass index. Aliment Pharmacol Ther 2011;33:1350–1360.
Journal of Hepatology 2015 vol. xxx j xxx–xxx 23
Please cite this article in press as: EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J
Hepatol (2015), http://dx.doi.org/10.1016/j.jhep.2015.04.006
of the NAFLD fibrosis score in a Chinese population with low prevalence of
advanced fibrosis. Am J Gastroenterol 2008;103:1682–1688. [140] Kirk GD, Astemborski J, Mehta SH, Spoler C, Fisher C, Allen D, et al.
Assessment of liver fibrosis by transient elastography in persons with
[119] Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nat Rev hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect
Gastroenterol Hepatol 2013;10:666–675. Dis 2009;48:963–972.
[120] Parkes J, Guha IN, Roderick P, Rosenberg W. Performance of serum [141] Pineda JA, Recio E, Camacho A, Macias J, Almodovar C, Gonzalez-Serrano M,
marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006;44: et al. Liver stiffness as a predictor of esophageal varices requiring therapy
462–474. in HIV/hepatitis C virus-coinfected patients with cirrhosis. J Acquir
Immune Defic Syndr 2009;51:445–449.
[121] Halfon P, Bacq Y, De Muret A, Penaranda G, Bourliere M, Ouzan D, et al.
Comparison of test performance profile for blood tests of liver fibrosis in [142] Sanchez-Conde M, Montes-Ramirez ML, Miralles P, Alvarez JM, Bellon JM,
chronic hepatitis C. J Hepatol 2007;46:395–402. Ramirez M, et al. Comparison of transient elastography and liver biopsy for
the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients
[122] Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, et al. and correlation with noninvasive serum markers. J Viral Hepat
Prospective comparison of six non-invasive scores for the diagnosis of liver 2010;17:280–286.
fibrosis in chronic hepatitis C. J Hepatol 2007;46:775–782.
[143] Castera L, Winnock M, Pambrun E, Paradis V, Perez P, Loko MA, et al.
[123] Cales P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, et al. Comparison of transient elastography (FibroScan), FibroTest, APRI and two
Evaluating the accuracy and increasing the reliable diagnosis rate of blood algorithms combining these non-invasive tests for liver fibrosis staging in
tests for liver fibrosis in chronic hepatitis C. Liver Int 2008;28:1352–1362. HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collab-
oration. HIV Med 2014;15:30–39.
[124] Degos F, Perez P, Roche B, Mahmoudi A, Asselineau J, Voitot H, et al.
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomark- [144] Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L,
ers in chronic viral hepatitis: a multicenter prospective study (the et al. Accuracy of liver stiffness measurement for the diagnosis of
FIBROSTIC study). J Hepatol 2010;53:1013–1021. cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:
1511–1517.
[125] Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, et al.
Comparison of nine blood tests and transient elastography for liver fibrosis [145] Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction
in chronic hepatitis C: The ANRS HCEP-23 study. J Hepatol 2012;56:55–62. of hepatitis C-related fibrosis: a systematic review of diagnostic test
accuracy. Am J Gastroenterol 2007;102:2589–2600.
[126] Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al.
Prospective comparison of transient elastography, Fibrotest, APRI, and liver [146] Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-
biopsy for the assessment of fibrosis in chronic hepatitis C. based transient elastography for the detection of hepatic Fibrosis:
Gastroenterology 2005;128:343–350. systematic review and meta-analysis. Clin Gastroenterol Hepatol
2007;5:1214–1220.
[127] Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al.
Noninvasive assessment of liver fibrosis by measurement of stiffness in [147] Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al.
patients with chronic hepatitis C. Hepatology 2005;41:48–54. Performance of transient elastography for the staging of liver fibrosis: a
meta-analysis. Gastroenterology 2008;134:960–974.
[128] Lupsor M, Badea R, Stefanescu H, Grigorescu M, Sparchez Z, Serban A, et al.
Analysis of histopathological changes that influence liver stiffness in [148] Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al. A
chronic hepatitis C. Results from a cohort of 324 patients. J Gastrointestin meta-analysis of transient elastography for the detection of hepatic
Liver Dis 2008;17:155–163. fibrosis. J Clin Gastroenterol 2010;44:214–219.
[129] Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, et al. [149] Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR,
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis Burroughs AK. Elastography for the diagnosis of severity of fibrosis in
in patients with hepatitis B or C: a United States multicenter study. Clin chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol
Gastroenterol Hepatol 2015;13:e773. 2011;54:650–659.
[130] Oliveri F, Coco B, Ciccorossi P, Colombatto P, Romagnoli V, Cherubini B, [150] Chon YE, Choi EH, Song KJ, Park JY, Kim do Y, Han KH, et al. Performance of
et al. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker transient elastography for the staging of liver fibrosis in patients with
of liver disease influenced by the pattern of transaminases. World J chronic hepatitis B: a meta-analysis. PLoS One 2012;7:e44930.
Gastroenterol 2008;14:6154–6162.
[151] Nahon P, Kettaneh A, Tengher-Barna I, Ziol M, de Ledinghen V, Douvin C,
[131] Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. et al. Assessment of liver fibrosis using transient elastography in patients
Non-invasive assessment of liver fibrosis by stiffness measurement in with alcoholic liver disease. J Hepatol 2008;49:1062–1068.
patients with chronic hepatitis B. Liver Int 2009;29:242–247.
[152] Fraquelli M, Rigamonti C, Casazza G, Donato MF, Ronchi G, Conte D, et al.
[132] Chan HL, Wong GL, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Alanine Etiology-related determinants of liver stiffness values in chronic viral
aminotransferase-based algorithms of liver stiffness measurement by hepatitis B or C. J Hepatol 2011;54:621–628.
transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
J Viral Hepat 2009;16:36–44. [153] Maimone S, Calvaruso V, Pleguezuelo M, Squadrito G, Amaddeo G, Jacobs
M, et al. An evaluation of transient elastography in the discrimination of
[133] Kim do Y, Kim SU, Ahn SH, Park JY, Lee JM, Park YN, et al. Usefulness of HBeAg-negative disease from inactive hepatitis B carriers. J Viral Hepat
FibroScan for detection of early compensated liver cirrhosis in chronic 2009;16:769–774.
hepatitis B. Dig Dis Sci 2009;54:1758–1763.
[154] Ngo Y, Benhamou Y, Thibault V, Ingiliz P, Munteanu M, Lebray P, et al. An
[134] Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, et al. accurate definition of the status of inactive hepatitis B virus carrier by a
FibroScan and ultrasonography in the prediction of hepatic fibrosis in combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS One
patients with chronic viral hepatitis. J Gastroenterol 2009; 44:439–446. 2008;3:e2573.
[135] Sporea I, Sirli R, Deleanu A, Tudora A, Popescu A, Curescu M, et al. Liver [155] Castera L, Bernard PH, Le Bail B, Foucher J, Trimoulet P, Merrouche W, et al.
stiffness measurements in patients with HBV vs. HCV chronic hepatitis: a Transient elastography and biomarkers for liver fibrosis assessment and
comparative study. World J Gastroenterol 2010;16:4832–4837. follow-up of inactive hepatitis B carriers. Aliment Pharmacol Ther
2011;33:455–465.
[136] Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP,
et al. Direct comparison of diagnostic performance of transient elas- [156] Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, et al.
tography in patients with chronic hepatitis B and chronic hepatitis C. Liver Noninvasive assessment of liver fibrosis by measurement of stiffness in
Int 2012;32:612–621. patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis
2008;40:371–378.
[137] Goyal R, Mallick SR, Mahanta M, Kedia S, Shalimar, Dhingra R, et al.
Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B. [157] Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, et al.
J Gastroenterol Hepatol 2013;28:1738–1745. Accuracy and reproducibility of transient elastography for the diagnosis of
fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008;48:
[138] de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. 442–448.
Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/
hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr [158] Lupsor M, Badea R, Stefanescu H, Grigorescu M, Serban A, Radu C, et al.
2006;41:175–179. Performance of unidimensional transient elastography in staging non-
alcoholic steatohepatitis. J Gastrointestin Liver Dis 2010;19:53–60.
[139] Vergara S, Macias J, Rivero A, Gutierrez-Valencia A, Gonzalez-Serrano M,
Merino D, et al. The use of transient elastometry for assessing liver fibrosis [159] Petta S, Di Marco V, Camma C, Butera G, Cabibi D, Craxi A. Reliability of liver
in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis stiffness measurement in non-alcoholic fatty liver disease: the effects of
2007;45:969–974. body mass index. Aliment Pharmacol Ther 2011;33:1350–1360.
Journal of Hepatology 2015 vol. xxx j xxx–xxx 23
Please cite this article in press as: EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J
Hepatol (2015), http://dx.doi.org/10.1016/j.jhep.2015.04.006
